Correvio Pharma Corp. Diluted Shares Outstanding (Weighted Average)
Correvio Pharma Corp. reported Diluted Shares Outstanding (Weighted Average) of 44.28 million shares for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2020-04-30
| Period end | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|
| 2019-12-31 | 44.28M shares 20-F · filed 2020-04-30 | |
| 2018-12-31 | 35.15M shares 20-F · filed 2020-04-30 | |
| 2017-12-31 | 33.23M shares 20-F · filed 2020-04-30 | |
| 2016-12-31 | 25.32M shares 20-F · filed 2018-04-30 | |
| 2015-12-31 | 18.20M shares 20-F · filed 2018-04-30 | |
| 2014-12-31 | 16.23M shares 40-F · filed 2015-03-27 | |
| 2013-12-31 | 12.93M shares 40-F · filed 2015-03-27 | |
| 2012-12-31 | 12.25M shares 40-F/A · filed 2014-04-30 | 61.27M shares 20-F/A · filed 2013-04-18 |
| 2011-12-31 | 61.13M shares 20-F/A · filed 2013-04-18 | |
| 2010-12-31 | 61.32M shares 20-F/A · filed 2013-04-18 |